Literature DB >> 30077996

Mechanism of action of vedolizumab: do we really understand it?

Gerhard Rogler.   

Abstract

Entities:  

Keywords:  antibody targeted therapy; immunology; inflammatory bowel disease; integrins; molecular mechanisms

Mesh：

Substances：

Year:  2018        PMID： 30077996     DOI： 10.1136/gutjnl-2018-316777

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Peripheral Enthesitis in Spondyloarthritis: Lessons from Targeted Treatments.

Authors:  Gurjit S Kaeley; Jaspreet K Kaler
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

Review 2.  Vedolizumab in Inflammatory Bowel Disease: West versus East.

Authors:  Prasanta Debnath; Pravin M Rathi
Journal:  Inflamm Intest Dis       Date:  2021-01-27

3.  Antibody secreting cells are critically dependent on integrin α4β7/MAdCAM-1 for intestinal recruitment and control of the microbiota during chronic colitis.

Authors:  Christopher J Tyler; Mauricio Guzman; Luke R Lundborg; Shaila Yeasmin; Nadia Zgajnar; Paul Jedlicka; Giorgos Bamias; Jesús Rivera-Nieves
Journal:  Mucosal Immunol       Date:  2021-08-25       Impact factor: 7.313
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.